Companies

Delphinus Medical Technologies

Delphinus Medical Solutions' principal product is SoftVue, an alternative to mammography for breast cancer detection, risk evaluation, and treatment monitoring. SoftVue can effectively differentiate benign from malignant masses in breasts, helping eliminate false positives and reducing unnecessary biopsies. It can also accurately measure breast density, a known risk factor for developing breast cancer, as well as detect many early stages of cancer in women with dense breast tissue, which is often not picked up by mammography. SoftVue works by surrounding a breast submerged in warm water with an ultrasound ring that captures detailed, three-dimensional images with sound waves. The results are similar to an MRI, but the procedure takes only a few minutes and costs much less. The procedure was the inspiration for the company's name, which is Latin for dolphins.